ToplineNovo Nordisk on Monday lowered the direct-to-consumer prices of its weight loss drug Wegovy and diabetes treatment Ozempic in a challenge to Eli Lilly’s Zepbound after President Donald Trump announced a deal with the pharmaceutical firms to reduce the U.S. price tag of the popular drugs. Trump announced popular weight loss treatments would be offered directly on a new “TrumpRx.gov” website at lower prices.Copyright 2023 The Associated Press. All rights reserved.Key FactsThe out-of-pocket monthly pric ...